Healio13h
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Semaglutide and Tirzepatide off FDA shortage list: What does this mean for weight loss drug access?
The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs ...
Everyday Health on MSN9h
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
US FDA expands approval for Alnylam's drug to treat rare heart disease
U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...
Managed Healthcare Executive10h
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi ...
JD Supra3d
FDA Update: Current Guidelines for Semaglutide and Tirzepatide Compounding
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...
The FDA can save lives by keeping copycat drugs off the market
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Yahoo Finance7d
Alnylam drug gets long-awaited FDA approval in deadly heart disease
Amvuttra will initially be priced in line with the cost in its other approved indication, for which a year’s supply has a ...
Fierce Pharma2d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
U.S. News & World Report7d
US FDA Expands Approval for Alnylam's Drug to Treat Rare Heart Disease
US FDA Expands Approval for Alnylam's Drug to Treat Rare ... For treating nerve damage, Amvuttra carries a list price of $119,351 per prefilled syringe and is given once every three months.